Search results for: Patricia Cubi-Molla
Filter search results
Save the Date: Drug Development in 2022, OHE’s 50th Anniversary Conference
21 June 2012
…Professor Patricia Danzon, The Wharton School, University of Pennsylvania Dr Hans-Georg Eichler, Senior Medical Officer, European Medicines Agency Dr Jens Grueger, Head, Global Health Economics and Pricing, Roche Pharmaceuticals Dr…
Register Now for the OHE Conference on Drug Development in 2022
2 July 2012
…Sir Alasdair Breckenridge, Chairman of the UK Medicines and Healthcare products Regulatory Agency (MHRA) Professor Patricia Danzon, The Wharton School, University of Pennsylvania Dr Hans-Georg Eichler, Senior Medical Officer, European…
European Medicines Pricing and Reimbursement: Now and the Future
1 January 2007
…Pricing and reimbursement policies in Spain: current and future trends; Overview Contributors: Claude Le Pen, J-Mattias von der Schulenburg, Martina Garau, Adrian Towse, Livio Garattini, Joan Costa-i-Font, Patricia Danzon 2007…
Women in Medicine: The Results of an Inquiry Conducted by the Medical Practitioners’ Union in 1962 – 63
1 July 1966
Share this: Download publication Patricia M. Elliott The results of an inquiry conducted by the Medical Practitioners’ Union in 1962-63. Share this: Download publication…
OHE Conference on Drug Development in 2022: Update
18 July 2012
…Innovations, University of Oxford Professor Sir Alasdair Breckenridge, Chairman of the UK Medicines and Healthcare products Regulatory Agency (MHRA) Professor Patricia Danzon, Celia Moh Professor, Professor of Health Care Management,…
Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition, and Procurement
17 February 2015
…an article by Patricia Danzon, Andrew Mulcahy, and Adrian Towse on the determinants of prices for pharmaceuticals in middle and low-income countries (MLICs). The paper uses a dataset spanning…
OHE at ISPOR Boston 2017: Presentations and Posters
4 July 2017
…questioning what we really mean by affordability in various contexts. Panellists Mark Sculpher (University of York), Patricia Danzon (University of Pennsylvania) and Steve Pearson (ICER) discussed cost-effectiveness analysis, budget thresholds,…
OHE at ISPOR Philadelphia Part 2: Risk Sharing, Medical Breakthroughs, Early Access and Drug Development Costs
12 May 2015
…Washington). Panelists: Adrian Towse (OHE), Joseph DiMasi (Tufts University), Patricia Danzon (University of Pennsylvania). DiMasi will present new evidence which suggest that drug development costs an average of $2.6…